HCPCS Level IIdrugActive
J1326
Inj, zolbetuximab-clzb, 2 mg
BETOS: O1D
Effective: 2025-07-01
Description
Injection, zolbetuximab-clzb, 2 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Vyloy
Manufacturer
Astellas Pharma US, Inc.
HCPCS Dosage
2 MG
Billing Units
50.0000
2
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.